Administering the same anti–PD-1 antibody used in the aging studies to young mice with experimental FSGS lowered proteinuria and glomerular collagen IV staining, accompanied by a higher podocyte density. This evidence concerns the gene PDCD1 and focal segmental glomerulosclerosis.